K2 Principal Fund, L.P. Ars Pharmaceuticals, Inc. Comm Transaction History

K2 Principal Fund, L.P.

  • $307 Million
  • Q4 2024

A detailed history of K2 Principal Fund, L.P. transactions in Ars Pharmaceuticals, Inc. Comm stock. As of the latest transaction made, K2 Principal Fund, L.P. holds 27,000 shares of SPRY stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,000
Previous 120,000 77.5%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024
SELL
N/A
-2,341,672 Reduced 95.13%
120,000 $0
Q2 2024

Aug 14, 2024
BUY
N/A
242,541 Added 10.93%
2,461,672 $0
Q1 2024

May 14, 2024
SELL
N/A
-835,202 Reduced 27.34%
2,219,131 $0
Q4 2023

Feb 14, 2024
BUY
N/A
502,271 Added 19.68%
3,054,333 $0
Q3 2023

Nov 13, 2023
BUY
N/A
1,280,318 Added 100.67%
2,552,062 $0
Q2 2023

Aug 14, 2023
SELL
N/A
-1,414,746 Reduced 52.66%
1,271,744 $0
Q1 2023

May 11, 2023
SELL
N/A
-185,658 Reduced 6.46%
2,686,490 $0
Q4 2022

Feb 10, 2023
SELL
N/A
-375,385 Reduced 11.56%
2,872,148 $0
Q3 2022

Nov 14, 2022
BUY
N/A
1,705,827 Added 110.65%
3,247,533 $16.9 Million
Q2 2022

Aug 12, 2022
BUY
N/A
1,541,706 New
1,541,706 $6.54 Million

About ARS PHARMACEUTICALS, INC. COMM

SPRY Quotes by TradingView
  • Ticker SPRY
More about SPRY
Track This Portfolio

Track K2 Principal Fund, L.P. Portfolio

Follow K2 Principal Fund, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of K2 Principal Fund, L.P., based on Form 13F filings with the SEC.

News

Stay updated on K2 Principal Fund, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email